Healthtech, day 2
summary
Three startups: a digital cognitive platform using eye‑tracking diagnostic tests tied to a five‑year Emory longitudinal study that predicts Alzheimer symptoms 3–6 years later and pairs testing with a virtual preventive therapy used by hundreds of thousands across 165+ countries; a marketplace for investigational drugs that legally ships pipeline therapies worldwide roughly seven years earlier than approval, bills insurers, and collects real‑world efficacy data; and an on‑demand doctor service doing 50,000 house calls so far, claiming $35M in savings, insurance billing, HIPAA compliance and ongoing regulatory hurdles.
AI-written summary · about
chapters (6)
related talks
20mThe future of healthcare
24mTechnology’s Next Frontiers
07mHow AI is Enabling Healthcare's Biggest Blindspot
19mThe future of AI in powering clinical trial innovation
20mTranslating a Trillion Pointo Diseases of Data into Therapies
23mEngineering AI-Powered Predictive Healthcare Systems
47mThe Future of Healthcare and AI
33mAI Healthcare – A Cybernetic Perspective
